Group 1 - The core viewpoint of the announcements is the disclosure of the main operational data for the pig farming business of Fujian Aonong Biological Technology Group Co., Ltd. for January 2026, highlighting significant growth in sales and inventory [1][2]. - In January 2026, the company sold 166,600 pigs, representing a year-on-year increase of 35.36% and a month-on-month increase of 2.63% compared to December 2025 [1]. - The pig inventory as of January 2026 was 758,600 pigs, which is a 54.84% increase compared to January 2025 and a 2.05% increase from the end of December 2025 [2]. Group 2 - The company is actively promoting the optimization of pig farming capacity, adjusting farming layout, scale, and breed structure, while continuing to focus on cost reduction and resource concentration to develop advantageous capacity [2]. - The disclosed operational data is based on internal statistics and is unaudited, intended to provide investors with timely insights into the company's pig farming business [3]. Group 3 - The announcements also include information regarding the shareholding status of major shareholders, specifically that the major shareholder, Zhangzhou Aonong Investment Co., Ltd., and its concerted actors hold a total of 328,255,547 shares, accounting for 12.6108% of the total share capital [6]. - As of February 6, 2026, the planned share reduction by certain shareholders, including Wu Youcai and Guo Qinghui, was not executed during the designated period [6][8].

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

Core Viewpoint - Aonong Biological (603363.SH) reported significant growth in pig sales and inventory for January 2026, indicating a strong performance in the swine industry [1] Group 1: Sales Performance - In January 2026, the company sold 166,600 pigs, representing a year-on-year increase of 35.36% and a month-on-month increase of 2.63% [1] Group 2: Inventory Levels - As of January 2026, the company's pig inventory stood at 758,600 heads, which is a 54.84% increase compared to January 2025 and a 2.05% increase from the end of December 2025 [1]

Core Viewpoint - Aonong Bio (603363.SH) reported a significant increase in pig sales and inventory for January 2026, indicating strong growth in the company's operations [1] Group 1: Sales Performance - In January 2026, the company sold 166,600 pigs, representing a year-on-year increase of 35.36% and a month-on-month increase of 2.63% [1] Group 2: Inventory Levels - As of January 2026, the company's pig inventory stood at 758,600 heads, which is a 54.84% increase compared to January 2025 and a 2.05% increase from the end of December 2025 [1]

减持计划时间届满暨未减持股份的结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 持股 5%以上股东及其一致行动人持股的基本情况 证券代码：603363 证券简称：傲农生物 公告编号：2026-009 福建傲农生物科技集团股份有限公司 持股 5%以上股东的一致行动人 截至本公告披露日，福建傲农生物科技集团股份有限公司（以下简称"公司"） 持股 5%以上股东漳州傲农投资有限公司（以下简称"傲农投资"）及其一致行动 人合计持有公司股份 328,255,547 股，占公司总股本的 12.6108%。其中傲农投 资的一致行动人吴有材持有公司股份 3,176,029 股，占公司总股本的 0.1220%， 郭庆辉先生持有公司股份 100,050 股，占公司总股本的 0.0038%。 减持计划的实施结果情况 截至 2026 年 2 月 6 日，吴有材先生、郭庆辉先生减持计划实施期间已届满。 公司于 2 月 6 日收到吴有材先生、郭庆辉先生出具的《减持股份结果告知函》， 两人在减持计划期间未减持公司股份。 | ...

福建傲农生物科技集团股份有限公司（以下简称"公司"）现将 2026 年 1 月养殖业务主要经营数据披露如下： 证券代码：603363 证券简称：傲农生物 公告编号：2026-008 福建傲农生物科技集团股份有限公司 2026 年 1 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、2026 年 1 月养殖业务主要经营数据 二、其他说明 本次披露的 2026 年 1 月养殖经营数据来自公司内部统计，未经审计，仅供 投资者及时了解本公司养殖业务生产经营概况，未对公司未来经营情况作出任何 承诺或保证，敬请投资者审慎使用，注意投资风险。 特此公告。 福建傲农生物科技集团股份有限公司董事会 2026 年 2 月 10 日 单位：万头 | 主要产品 | 销售量 | 库存量 | 销售量同比 增减（%） | 库存量同比 增减（%） | | --- | --- | --- | --- | --- | | 生猪 | 16.66 | 75.86 | +35.36 | +54.84 | 2026 年 1 月，公司生猪销 ...

Group 1 - The core viewpoint of the article is that Aonong Biological (603363) reported significant growth in both pig sales and inventory for January 2026 compared to previous periods [1] Group 2 - In January 2026, the company sold 166,600 pigs, representing a year-on-year increase of 35.36% and a month-on-month increase of 2.63% [1] - The company's pig inventory reached 758,600 heads in January 2026, which is a 54.84% increase compared to January 2025 and a 2.05% increase compared to the end of December 2025 [1]

Core Viewpoint - Aonong Biological (603363.SH) reported a significant increase in pig sales and inventory for January 2026, indicating a positive trend in its operational performance [1] Group 1: Sales Performance - In January 2026, the company sold 166,600 pigs, representing a year-on-year increase of 35.36% and a month-on-month increase of 2.63% [1] Group 2: Inventory Levels - The company's pig inventory reached 758,600 heads in January 2026, which is a 54.84% increase compared to January 2025 and a 2.05% increase from the end of December 2025 [1] Group 3: Operational Strategy - The company is actively optimizing its pig farming capacity by adjusting breeding layout, scale, and breed structure, while continuing to focus on cost reduction and resource concentration to develop advantageous capacity [1]

Core Viewpoint - Aonong Bio (603363.SH) announced that the share reduction plan by Mr. Wu Youcai and Mr. Guo Qinghui has expired, and neither of them has reduced their shareholdings during the plan period [1] Summary by Category - Company Actions - Aonong Bio received a notification letter from Mr. Wu Youcai and Mr. Guo Qinghui stating that they did not reduce their shares during the reduction plan period [1]

Core Viewpoint - Aonong Biological (603363.SH) reported a significant increase in pig sales and inventory for January 2026, indicating strong operational performance and strategic focus on cost reduction and capacity optimization [1] Group 1: Sales Performance - In January 2026, the company sold 166,600 pigs, representing a year-on-year increase of 35.36% and a month-on-month increase of 2.63% [1] - The total pig inventory stood at 758,600 heads in January 2026, which is a 54.84% increase compared to January 2025 and a 2.05% increase from the end of December 2025 [1] Group 2: Strategic Focus - The company is actively promoting optimization of pig farming capacity by adjusting breeding layout, scale, and breed structure [1] - The company will continue to adhere to a strategy focused on stability and ongoing cost reduction, concentrating resources on developing advantageous capacity and pragmatic operational goals [1]